# Foresite Capital Management VI LLC 13F Q2 2026: $643 million

Foresite Capital Management VI LLC reported $643 million in 13F securities across 23 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was CG Oncology Inc at $168 million, 26.2% of the reported value. Since Q1 2026 it opened 8 new positions and exited 2.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $642,575,985
- Positions: 23
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 2013341
- Form 13F file number: 028-25267
- Business address: 9200 Sunset Boulevard Suite Ph1, West Hollywood, CA 90069
- SEC filing: [0001104659-26-097133](https://www.sec.gov/Archives/edgar/data/2013341/000110465926097133/0001104659-26-097133-index.htm)

## Top 23 holdings by value

The largest of 23 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 2,369,574 | $168.4 million | +148,100 |
| [Alumis Inc](https://specstream.ai/data/institutional-holders/alumis-inc-022307102) | COM | 4,247,670 | $119.5 million | No change |
| [Seaport Therapeutics Inc](https://specstream.ai/data/institutional-holders/seaport-therapeutics-inc-81221k108) | COMMON STOCK | 1,779,521 | $38.7 million | New |
| [Denali Therapeutics Inc](https://specstream.ai/data/institutional-holders/denali-therapeutics-inc-24823r105) | COM | 1,396,771 | $35.9 million | +186,800 |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 879,713 | $32.7 million | +563,800 |
| [Agios Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/agios-pharmaceuticals-inc-00847x104) | COM | 785,000 | $29.1 million | +260,000 |
| [Corvus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/corvus-pharmaceuticals-inc-221015100) | COM | 1,831,233 | $27.4 million | No change |
| [Parabilis Medicines Inc](https://specstream.ai/data/institutional-holders/parabilis-medicines-inc-698955101) | COM | 999,044 | $27.3 million | New |
| [GH Research PLC](https://specstream.ai/data/institutional-holders/gh-research-plc-g3855l106) | ORDINARY SHARES | 940,493 | $25.3 million | +625,001 |
| [Jade Biosciences Inc](https://specstream.ai/data/institutional-holders/jade-biosciences-inc-008064206) | COM NEW | 886,667 | $19.7 million | +566,667 |
| [Hinge Health Inc](https://specstream.ai/data/institutional-holders/hinge-health-inc-433313103) | CL A | 220,400 | $18.3 million | No change |
| [Kymera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kymera-therapeutics-inc-501575104) | COM | 146,332 | $16.8 million | No change |
| [Ataibeckley Inc](https://specstream.ai/data/institutional-holders/ataibeckley-inc-04650f101) | COM SHS | 2,750,000 | $14.5 million | No change |
| [Verastem Inc](https://specstream.ai/data/institutional-holders/verastem-inc-92337c203) | COM NEW | 3,146,631 | $12 million | No change |
| [Beam Therapeutics Inc](https://specstream.ai/data/institutional-holders/beam-therapeutics-inc-07373v105) | COM | 330,000 | $11.3 million | New |
| [Minerva Neurosciences Inc](https://specstream.ai/data/institutional-holders/minerva-neurosciences-inc-603380205) | COM NEW | 1,985,584 | $11 million | -1,016 |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 301,341 | $10.5 million | New |
| [Aura Biosciences Inc](https://specstream.ai/data/institutional-holders/aura-biosciences-inc-05153u107) | COM | 1,333,334 | $9.5 million | New |
| [Crinetics Pharmaceuticals in](https://specstream.ai/data/institutional-holders/crinetics-pharmaceuticals-in-22663k107) | COM | 212,010 | $7.9 million | No change |
| [Research Alliance Corp III](https://specstream.ai/data/institutional-holders/research-alliance-corp-iii-g75226103) | ORD SHS CL A | 300,000 | $3.2 million | New |
| [Zura Bio LTD](https://specstream.ai/data/institutional-holders/zura-bio-ltd-g9ty5a101) | CLASS A ORD SHS | 450,000 | $2.7 million | No change |
| [Kailera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kailera-therapeutics-inc-482931102) | COMMON STOCK | 37,500 | $826,125 | New |
| [Disc Medicine Inc](https://specstream.ai/data/institutional-holders/disc-medicine-inc-254604101) | COM | 970 | $70,946 | New |

## New positions in Q2 2026

8 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Seaport Therapeutics Inc](https://specstream.ai/data/institutional-holders/seaport-therapeutics-inc-81221k108) | COMMON STOCK | 1,779,521 | $38.7 million |
| [Parabilis Medicines Inc](https://specstream.ai/data/institutional-holders/parabilis-medicines-inc-698955101) | COM | 999,044 | $27.3 million |
| [Beam Therapeutics Inc](https://specstream.ai/data/institutional-holders/beam-therapeutics-inc-07373v105) | COM | 330,000 | $11.3 million |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 301,341 | $10.5 million |
| [Aura Biosciences Inc](https://specstream.ai/data/institutional-holders/aura-biosciences-inc-05153u107) | COM | 1,333,334 | $9.5 million |
| [Research Alliance Corp III](https://specstream.ai/data/institutional-holders/research-alliance-corp-iii-g75226103) | ORD SHS CL A | 300,000 | $3.2 million |
| [Kailera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kailera-therapeutics-inc-482931102) | COMMON STOCK | 37,500 | $826,125 |
| [Disc Medicine Inc](https://specstream.ai/data/institutional-holders/disc-medicine-inc-254604101) | COM | 970 | $70,946 |

## Positions exited in Q2 2026

2 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 1,364,019 | $54.2 million |
| [Onkure Therapeutics Inc](https://specstream.ai/data/institutional-holders/onkure-therapeutics-inc-68277q105) | COM CL A | 1,445,783 | $6 million |

## Also on SpecStream

- [Foresite Capital Management VI LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/2013341/000110465926097133/0001104659-26-097133-index.htm)
- [Largest 13F filers in California](https://specstream.ai/data/institutional-holdings/state/california)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in West Hollywood, California

- [Marketing agencies in West Hollywood, California](https://specstream.ai/data/businesses/marketing-agencies/west-hollywood-california-united-states)
- [Financial services firms in West Hollywood, California](https://specstream.ai/data/businesses/financial-services-firms/west-hollywood-california-united-states)
- [Video production companies in West Hollywood, California](https://specstream.ai/data/businesses/video-production-companies/west-hollywood-california-united-states)
- [Real estate firms in West Hollywood, California](https://specstream.ai/data/businesses/real-estate-firms/west-hollywood-california-united-states)
- [Hotels in West Hollywood, California](https://specstream.ai/data/businesses/hotels/west-hollywood-california-united-states)
- [American restaurants in West Hollywood, California](https://specstream.ai/data/businesses/american-restaurants/west-hollywood-california-united-states)
